\relax 
\providecommand*\new@tpo@label[2]{}
\abx@aux@refcontext{none/global//global/global/global}
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\providecommand\BKM@entry[2]{}
\BKM@entry{id=1,dest={73656374696F6E2A2E32},srcline={153}}{5C3337365C3337375C303030425C303030615C303030635C3030306B5C303030675C303030725C3030306F5C303030755C3030306E5C30303064}
\abx@aux@cite{0}{grace_dopamine_2012}
\abx@aux@segm{0}{0}{grace_dopamine_2012}
\abx@aux@cite{0}{grace_dysregulation_2016}
\abx@aux@segm{0}{0}{grace_dysregulation_2016}
\abx@aux@cite{0}{merritt_nature_2017}
\abx@aux@segm{0}{0}{merritt_nature_2017}
\abx@aux@cite{0}{kraguljac_increased_2013}
\abx@aux@segm{0}{0}{kraguljac_increased_2013}
\abx@aux@cite{0}{marsman_glutamate_2013}
\abx@aux@segm{0}{0}{marsman_glutamate_2013}
\abx@aux@cite{0}{nakahara_glutamatergic_2022}
\abx@aux@segm{0}{0}{nakahara_glutamatergic_2022}
\abx@aux@cite{0}{jeon_progressive_2021}
\abx@aux@segm{0}{0}{jeon_progressive_2021}
\abx@aux@cite{0}{merritt_nature_2017}
\abx@aux@segm{0}{0}{merritt_nature_2017}
\abx@aux@cite{0}{nakahara_glutamatergic_2022}
\abx@aux@segm{0}{0}{nakahara_glutamatergic_2022}
\abx@aux@cite{0}{merritt_nature_2017}
\abx@aux@segm{0}{0}{merritt_nature_2017}
\abx@aux@cite{0}{bojesen_treatment_2020}
\abx@aux@segm{0}{0}{bojesen_treatment_2020}
\abx@aux@cite{0}{jeon_progressive_2021}
\abx@aux@segm{0}{0}{jeon_progressive_2021}
\abx@aux@cite{0}{egerton_effects_2017}
\abx@aux@segm{0}{0}{egerton_effects_2017}
\abx@aux@cite{0}{fan_glutamatergic_2024}
\abx@aux@segm{0}{0}{fan_glutamatergic_2024}
\abx@aux@cite{0}{reyes-madrigal_striatal_2022}
\abx@aux@segm{0}{0}{reyes-madrigal_striatal_2022}
\abx@aux@cite{0}{reyes-madrigal_striatal_2022}
\abx@aux@segm{0}{0}{reyes-madrigal_striatal_2022}
\abx@aux@cite{0}{egerton_response_2018}
\abx@aux@segm{0}{0}{egerton_response_2018}
\abx@aux@cite{0}{nakazawa_spatial_2017}
\abx@aux@segm{0}{0}{nakazawa_spatial_2017}
\abx@aux@cite{0}{beck_association_2020}
\abx@aux@segm{0}{0}{beck_association_2020}
\abx@aux@cite{0}{balla_continuous_2001}
\abx@aux@segm{0}{0}{balla_continuous_2001}
\abx@aux@cite{0}{grace_dopamine_2012}
\abx@aux@segm{0}{0}{grace_dopamine_2012}
\abx@aux@cite{0}{grace_dysregulation_2016}
\abx@aux@segm{0}{0}{grace_dysregulation_2016}
\@writefile{toc}{\contentsline {section}{\nonumberline Background}{1}{section*.2}\protected@file@percent }
\newlabel{background}{{}{1}{Background}{section*.2}{}}
\abx@aux@cite{0}{howes_synaptic_2023}
\abx@aux@segm{0}{0}{howes_synaptic_2023}
\abx@aux@cite{0}{glantz_apoptotic_2006}
\abx@aux@segm{0}{0}{glantz_apoptotic_2006}
\abx@aux@cite{0}{osimo_synaptic_2019}
\abx@aux@segm{0}{0}{osimo_synaptic_2019}
\abx@aux@cite{0}{radhakrishnan_vivo_2021}
\abx@aux@segm{0}{0}{radhakrishnan_vivo_2021}
\abx@aux@cite{0}{onwordi_synaptic_2020}
\abx@aux@segm{0}{0}{onwordi_synaptic_2020}
\abx@aux@cite{0}{onwordi_relationship_2021}
\abx@aux@segm{0}{0}{onwordi_relationship_2021}
\abx@aux@cite{0}{onwordi_relationship_2021}
\abx@aux@segm{0}{0}{onwordi_relationship_2021}
\abx@aux@cite{0}{wang_levetiracetam_2017}
\abx@aux@segm{0}{0}{wang_levetiracetam_2017}
\abx@aux@cite{0}{roeske_modulation_2023}
\abx@aux@segm{0}{0}{roeske_modulation_2023}
\abx@aux@cite{0}{goff_levetiracetam_2020}
\abx@aux@segm{0}{0}{goff_levetiracetam_2020}
\abx@aux@cite{0}{contreras-garcia_levetiracetam_2022}
\abx@aux@segm{0}{0}{contreras-garcia_levetiracetam_2022}
\abx@aux@cite{0}{luzadriana_effect_2018}
\abx@aux@segm{0}{0}{luzadriana_effect_2018}
\abx@aux@cite{0}{contreras-garcia_synaptic_2021}
\abx@aux@segm{0}{0}{contreras-garcia_synaptic_2021}
\abx@aux@cite{0}{meehan_levetiracetam_2012}
\abx@aux@segm{0}{0}{meehan_levetiracetam_2012}
\abx@aux@cite{0}{yang_prolonged_2007}
\abx@aux@segm{0}{0}{yang_prolonged_2007}
\abx@aux@cite{0}{lee_levetiracetam_2009}
\abx@aux@segm{0}{0}{lee_levetiracetam_2009}
\BKM@entry{id=2,dest={73656374696F6E2A2E34},srcline={257}}{5C3337365C3337375C303030415C303030695C3030306D5C303030735C3030305C3034305C303030615C3030306E5C303030645C3030305C3034305C3030306F5C303030625C3030306A5C303030655C303030635C303030745C303030695C303030765C303030655C30303073}
\BKM@entry{id=3,dest={73656374696F6E2A2E36},srcline={279}}{5C3337365C3337375C303030485C303030795C303030705C3030306F5C303030745C303030685C303030655C303030735C303030655C303030735C3030305C3034305C303030755C3030306E5C303030645C303030655C303030725C3030305C3034305C303030695C3030306E5C303030765C303030655C303030735C303030745C303030695C303030675C303030615C303030745C303030695C3030306F5C3030306E}
\abx@aux@cite{0}{meehan_new_2011}
\abx@aux@segm{0}{0}{meehan_new_2011}
\abx@aux@cite{0}{meehan_levetiracetam_2012}
\abx@aux@segm{0}{0}{meehan_levetiracetam_2012}
\abx@aux@cite{0}{meehan_new_2011}
\abx@aux@segm{0}{0}{meehan_new_2011}
\abx@aux@cite{0}{loscher_synaptic_2016}
\abx@aux@segm{0}{0}{loscher_synaptic_2016}
\abx@aux@cite{0}{roeske_modulation_2023}
\abx@aux@segm{0}{0}{roeske_modulation_2023}
\abx@aux@cite{0}{goff_levetiracetam_2020}
\abx@aux@segm{0}{0}{goff_levetiracetam_2020}
\BKM@entry{id=4,dest={73656374696F6E2A2E38},srcline={306}}{5C3337365C3337375C3030304D5C303030655C303030745C303030685C3030306F5C303030645C3030306F5C3030306C5C3030306F5C303030675C30303079}
\BKM@entry{id=5,dest={73756273656374696F6E2A2E3130},srcline={309}}{5C3337365C3337375C303030535C303030745C303030755C303030645C303030795C3030305C3034305C303030645C303030655C303030735C303030695C303030675C3030306E5C3030305C3034305C303030615C3030306E5C303030645C3030305C3034305C303030645C303030615C303030745C303030615C3030305C3034305C303030635C3030306F5C3030306C5C3030306C5C303030655C303030635C303030745C303030695C3030306F5C3030306E}
\BKM@entry{id=6,dest={73756273756273656374696F6E2A2E3132},srcline={311}}{5C3337365C3337375C303030535C303030745C303030755C303030645C303030795C3030305C3034305C303030645C303030655C303030735C303030695C303030675C3030306E}
\@writefile{toc}{\contentsline {section}{\nonumberline Aims and objectives}{3}{section*.4}\protected@file@percent }
\newlabel{aims-and-objectives}{{}{3}{Aims and objectives}{section*.4}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Hypotheses under investigation}{3}{section*.6}\protected@file@percent }
\newlabel{hypotheses-under-investigation}{{}{3}{Hypotheses under investigation}{section*.6}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Methodology}{3}{section*.8}\protected@file@percent }
\newlabel{methodology}{{}{3}{Methodology}{section*.8}{}}
\@writefile{toc}{\contentsline {subsection}{\nonumberline Study design and data collection}{3}{subsection*.10}\protected@file@percent }
\newlabel{study-design-and-data-collection}{{}{3}{Study design and data collection}{subsection*.10}{}}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Study design}{3}{subsubsection*.12}\protected@file@percent }
\newlabel{study-design}{{}{3}{Study design}{subsubsection*.12}{}}
\BKM@entry{id=7,dest={73756273756273656374696F6E2A2E3135},srcline={343}}{5C3337365C3337375C303030535C303030615C3030306D5C303030705C3030306C5C303030655C3030305C3034305C303030735C303030695C3030307A5C30303065}
\abx@aux@cite{0}{egerton_effects_2017}
\abx@aux@segm{0}{0}{egerton_effects_2017}
\BKM@entry{id=8,dest={73756273756273656374696F6E2A2E3137},srcline={349}}{5C3337365C3337375C3030304D5C303030655C303030615C303030735C303030755C303030725C303030695C3030306E5C303030675C3030305C3034305C303030675C3030306C5C303030755C303030745C303030615C3030306D5C303030615C303030745C30303065}
\abx@aux@cite{0}{onwordi_synaptic_2020}
\abx@aux@segm{0}{0}{onwordi_synaptic_2020}
\abx@aux@cite{0}{onwordi_relationship_2021}
\abx@aux@segm{0}{0}{onwordi_relationship_2021}
\BKM@entry{id=9,dest={73756273756273656374696F6E2A2E3139},srcline={367}}{5C3337365C3337375C303030425C303030655C303030685C303030615C303030765C303030695C3030306F5C303030755C303030725C303030615C3030306C5C3030305C3034305C3030306D5C303030655C303030615C303030735C303030755C303030725C303030655C30303073}
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces Study design: participants are randomised into the order in which they receive the placebo and levetiracetam (HC= healthy controls, SZ=participatns with schizophrenia)}}{4}{figure.caption.13}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig-study_design}{{1}{4}{Study design: participants are randomised into the order in which they receive the placebo and levetiracetam (HC= healthy controls, SZ=participatns with schizophrenia)}{figure.caption.13}{}}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Sample size}{4}{subsubsection*.15}\protected@file@percent }
\newlabel{sample-size}{{}{4}{Sample size}{subsubsection*.15}{}}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Measuring glutamate}{4}{subsubsection*.17}\protected@file@percent }
\newlabel{measuring-glutamate}{{}{4}{Measuring glutamate}{subsubsection*.17}{}}
\BKM@entry{id=10,dest={73756273656374696F6E2A2E3231},srcline={380}}{5C3337365C3337375C303030415C3030306E5C303030615C3030306C5C303030795C303030735C303030695C30303073}
\BKM@entry{id=11,dest={73756273756273656374696F6E2A2E3233},srcline={382}}{5C3337365C3337375C303030435C303030685C303030615C3030306E5C303030675C303030655C3030305C3034305C303030695C3030306E5C3030305C3034305C303030675C3030306C5C303030755C303030745C303030615C3030306D5C303030615C303030745C30303065}
\BKM@entry{id=12,dest={73756273756273656374696F6E2A2E3236},srcline={422}}{5C3337365C3337375C303030435C303030685C303030615C3030306E5C303030675C303030655C3030305C3034305C303030695C3030306E5C3030305C3034305C303030735C303030795C3030306D5C303030705C303030745C3030306F5C3030306D5C30303073}
\BKM@entry{id=13,dest={73656374696F6E2A2E3238},srcline={432}}{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}
\BKM@entry{id=14,dest={73756273656374696F6E2A2E3330},srcline={434}}{5C3337365C3337375C303030505C303030725C3030306F5C303030675C303030725C303030655C303030735C303030735C3030305C3034305C303030775C303030695C303030745C303030685C3030305C3034305C303030725C303030655C303030635C303030725C303030755C303030695C303030745C3030306D5C303030655C3030306E5C30303074}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Behavioural measures}{5}{subsubsection*.19}\protected@file@percent }
\newlabel{behavioural-measures}{{}{5}{Behavioural measures}{subsubsection*.19}{}}
\@writefile{toc}{\contentsline {subsection}{\nonumberline Analysis}{5}{subsection*.21}\protected@file@percent }
\newlabel{analysis}{{}{5}{Analysis}{subsection*.21}{}}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Change in glutamate}{5}{subsubsection*.23}\protected@file@percent }
\newlabel{change-in-glutamate}{{}{5}{Change in glutamate}{subsubsection*.23}{}}
\@writefile{toc}{\contentsline {subsubsection}{\nonumberline Change in symptoms}{5}{subsubsection*.26}\protected@file@percent }
\newlabel{change-in-symptoms}{{}{5}{Change in symptoms}{subsubsection*.26}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Progress made to date, including pilot work, if applicable}{5}{section*.28}\protected@file@percent }
\newlabel{progress-made-to-date-including-pilot-work-if-applicable}{{}{5}{Progress made to date, including pilot work, if applicable}{section*.28}{}}
\@writefile{toc}{\contentsline {subsection}{\nonumberline Progress with recruitment}{5}{subsection*.30}\protected@file@percent }
\newlabel{progress-with-recruitment}{{}{5}{Progress with recruitment}{subsection*.30}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces Comparison of Glu levels change between placebo and levetiracetam in HC and SZ}}{6}{figure.caption.24}\protected@file@percent }
\newlabel{fig-lev_hc_vs_sz}{{2}{6}{Comparison of Glu levels change between placebo and levetiracetam in HC and SZ}{figure.caption.24}{}}
\BKM@entry{id=15,dest={73756273656374696F6E2A2E3332},srcline={454}}{5C3337365C3337375C303030505C303030725C3030306F5C303030675C303030725C303030655C303030735C303030735C3030305C3034305C303030775C303030695C303030745C303030685C3030305C3034305C303030615C3030306E5C303030615C3030306C5C303030795C303030735C303030655C30303073}
\BKM@entry{id=16,dest={73656374696F6E2A2E3334},srcline={460}}{5C3337365C3337375C303030505C3030306C5C303030615C3030306E5C3030306E5C303030655C303030645C3030305C3034305C303030665C303030755C303030745C303030755C303030725C303030655C3030305C3034305C303030775C3030306F5C303030725C3030306B}
\BKM@entry{id=17,dest={73656374696F6E2A2E3336},srcline={473}}{5C3337365C3337375C303030435C3030306F5C3030306E5C303030745C303030725C303030695C303030625C303030755C303030745C303030695C3030306F5C3030306E5C3030305C3034305C303030745C3030306F5C3030305C3034305C303030655C303030785C303030695C303030735C303030745C303030695C3030306E5C303030675C3030305C3034305C3030306B5C3030306E5C3030306F5C303030775C3030306C5C303030655C303030645C303030675C303030655C3030302E}
\abx@aux@cite{0}{radhakrishnan_vivo_2021}
\abx@aux@segm{0}{0}{radhakrishnan_vivo_2021}
\abx@aux@cite{0}{onwordi_synaptic_2020}
\abx@aux@segm{0}{0}{onwordi_synaptic_2020}
\BKM@entry{id=18,dest={73656374696F6E2A2E3338},srcline={489}}{5C3337365C3337375C303030505C303030655C303030725C303030735C3030306F5C3030306E5C303030615C3030306C5C3030305C3034305C303030735C303030685C303030615C303030725C303030655C3030305C3034305C303030695C3030306E5C3030305C3034305C303030695C3030306E5C303030765C303030655C303030735C303030745C303030695C303030675C303030615C303030745C303030695C3030306F5C3030306E5C30303073}
\BKM@entry{id=19,dest={73656374696F6E2A2E3430},srcline={499}}{5C3337365C3337375C303030545C303030695C3030306D5C303030655C3030306C5C303030695C3030306E5C303030655C3030305C3034305C303030665C3030306F5C303030725C3030305C3034305C303030745C303030685C303030655C3030305C3034305C303030725C303030655C3030306D5C303030615C303030695C3030306E5C303030645C303030655C303030725C3030305C3034305C3030306F5C303030665C3030305C3034305C303030735C303030745C303030755C303030645C303030695C303030655C303030735C3030302E}
\@writefile{toc}{\contentsline {subsection}{\nonumberline Progress with analyses}{7}{subsection*.32}\protected@file@percent }
\newlabel{progress-with-analyses}{{}{7}{Progress with analyses}{subsection*.32}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Planned future work}{7}{section*.34}\protected@file@percent }
\newlabel{planned-future-work}{{}{7}{Planned future work}{section*.34}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Contribution to existing knowledge.}{7}{section*.36}\protected@file@percent }
\newlabel{contribution-to-existing-knowledge.}{{}{7}{Contribution to existing knowledge}{section*.36}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Personal share in investigations}{7}{section*.38}\protected@file@percent }
\newlabel{personal-share-in-investigations}{{}{7}{Personal share in investigations}{section*.38}{}}
\@writefile{toc}{\contentsline {section}{\nonumberline Timeline for the remainder of studies.}{8}{section*.40}\protected@file@percent }
\newlabel{timeline-for-the-remainder-of-studies.}{{}{8}{Timeline for the remainder of studies}{section*.40}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces Gantt chart of planned work during my PhD}}{8}{figure.caption.41}\protected@file@percent }
\newlabel{fig-gantt-chart}{{3}{8}{Gantt chart of planned work during my PhD}{figure.caption.41}{}}
\BKM@entry{id=20,dest={73656374696F6E2A2E3433},srcline={535}}{5C3337365C3337375C303030525C303030655C303030665C303030655C303030725C303030655C3030306E5C303030635C303030655C30303073}
\@writefile{toc}{\contentsline {section}{\nonumberline References}{9}{section*.43}\protected@file@percent }
\newlabel{references}{{}{9}{References}{section*.43}{}}
\abx@aux@read@bbl@mdfivesum{nohash}
\abx@aux@read@bblrerun
\gdef \@abspage@last{9}
